Human Oncology & Pathogenesis Program
The Nikolaus Schultz Lab
Research

The Schultz lab focuses on identifying the genomic alterations that underlie different types of cancer. By applying existing and novel computational methods to large scale cancer genomics data sets, the lab aims to better understand the complex mechanisms at the gene and at the pathway level that drive tumor initiation, progression and response to therapy, with the ultimate goal of identifying targeted therapeutic options for cancer patients. A new focus of the lab is the systematic extraction and standardization of clinical data elements from electronic health records. The lab is also involved in collaborative large-scale projects such as The Cancer Genome Atlas (TCGA), AACR Project GENIE, and the Human Tumor Atlas (HTAN). The group also has a strong interest in enabling discoveries by developing novel computational methods and databases that help bridge the divide between computer scientists on one side and clinicians and researchers on the other. Examples of these include the cBioPortal for Cancer Genomics, a popular resource for the visualization and analysis of cancer genomics data, and OncoKB®, a precision oncology knowledgebase.

Featured News



Publications
Chakravarty D, Gao J, Phillips SM, Kundra R, et al. OncoKB: A Precision Oncology Knowledge Base. JCO Precis Oncol. 2017 Jul.
People

Nikolaus Schultz, PhD
Director, Cancer Data Science Initiative; Head of Knowledge Systems, Marie-Josée & Henry R. Kravis Center for Molecular Oncology; Attending Computational Oncologist, Department of Epidemiology & Biostatistics
- Cancer biologist Nikolaus Schultz uses computational tools to study the diversity of genomic alterations underlying different cancer types.
- PhD, Freie Universitat Berlin
- [email protected]
- Email Address
- Download CV
- PDF File
Members

- BS, Yale University




















- BS, The Hong Kong University of Science and Technology





Research Fellow
Research Fellow

WGS Student

PGY1; Postdoc, Computational Oncology

Assistant Attending; Lead Scientist, OncoKB

Graduate Student

Bioinformatics Software Engineer

Bioinformatics Software Engineer

Head of CMO Data Engineering
Senior Computational Biologist

Graduate Research Assistant

Bioinformatics Software Engineer

Bioinformatics Software Engineer

Lead Bioinformatics Software Engineer
Bioinformatics Software Engineer

Bioinformatics Software Engineer
Bioinformatics Software Engineer

Computational Biologist

Bioinformatics Software Engineer

Bioinformatics Software Engineer

Scientific Editor, OncoKB

Lead Engineer, SMILE

Senior Scientific Editor, OncoKB

Associate Director, CRC Initiatives

Assistant Attending

Bioinformatics Software Engineer

Lead Bioinformatics Engineer


Software Engineer
WGS Graduate Student

Computational Biologist

Bioinformatics Software Engineer
Senior Computational Biologist

Bioinformatics Software Engineer

Bioinformatics Software Engineer












Lab Alumni

Bioinformatics Software Engineer

Research Fellow

Data Curator
Computational Engineer

Assistant Attending

Bioinformatics Engineer

Graduate Student
Computational Engineer

Research Scholar

Bioinformatics Engineer
Manager, Biocomputing

Bioinformatics Software Engineer

Bioinformatics Software Engineer

Bioinformatics Software Engineer

Bioinformatics Software Engineer

Bioinformatics Software Engineer
Bioinformatics Software Engineer
Lab Affiliations
Achievements
- Geoffrey Beene Junior Faculty Chair (2019)
- Josie Robertson Investigator (2013-2018)
- Stupski Prize in Prostate Cancer Computational Oncology (2015)
- Young Investigator Award, Prostate Cancer Foundation (2014)
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Postdoctoral Researcher, Cancer Genomics – Schultz Laboratory Memorial Sloan Kettering Cancer Center
Get in Touch
-
Lab Head Email
-
Lab Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Nikolaus Schultz discloses the following relationships and financial interests:
-
Cambridge Innovation Institute
Provision of Services (uncompensated) -
Harvard T.H. Chan School of Public Health
Provision of Services (uncompensated)
-
Innovation in Cancer Informatics
Provision of Services (uncompensated) -
Seoul National University
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].